Accuracy and Precision in Bioanalysis: Review of Case Studies – June 17, 2019

Drs. Charles Bonapace and Arindam Dasgupta from CDER’s Division of New Drug Bioequivalence Evaluation and Office of Study Integrity and Surveillance discuss expectations for high-quality bioanalytical data.

_______________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Phone: [phone] I [phone]